Oct 20 (Reuters) – Verrica Pharmaceuticals Inc: * VERRICA PHARMACEUTICALS RECEIVES POSITIVE FEEDBACK FROM THE EUROPEAN MEDICINES AGENCY (EMA) SUPPORTING A CLEAR REGULATORY PATH FORWARD TO FILE FOR APPROVAL OF YCANTH® IN THE EUROPEAN UNION * VERRICA PHARMACEUTICALS INC – PLANS REGULATORY SUBMISSION FOR YCANTH BY Q4 2026 Source text: Further company coverage:
(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)
Berlin (dpa) - People react differently to heat, with some fine even as temperatures soar,…
Mumbai (Maharashtra) [India], June 26: In a significant move aimed at strengthening environmental governance and…
Jamshedpur (Jharkhand) [India], June 26: XLRI – Xavier School of Management has been awarded the…
For years, the adventures of the little yellow Minions have been delighting cinema-goers. In their…
By Danielle Broadway Los Angeles, June 25 (Reuters) - "The Invite," an American comedy film…
Noida (Uttar Pradesh) [India], June 25: In an era where technology is redefining every aspect…